Arab Finance: Ibnsina Pharma and Sandoz Egypt Pharma inked a distribution and promotion agreement for the Sandoz over-the-counter (OTC) portfolio of products, according to an EGX disclosure on January 29th.
“Our partnership with a recognized global leader like Sandoz is a testament that Ibnsina Pharma is the distributor of choice. The partnership will also boost our efforts to bring products to everyone in need, wherever they are,” Co-Founder and Co-CEO of Ibnsina Pharma Mahmoud Abdel Gawad said.
Sameh Elbagoury, General Manager at Sandoz Egypt and Libya, commented: “Our OTC portfolio in Egypt currently spans eight products and we have concrete plans to expand, transforming it into one of our strategic pillars, alongside our generic and biosimilar drug portfolios.”
Established in 2001, Ibnsina Pharma is Egypt’s fastest-growing and second-largest pharmaceutical distribution company, with a competitive portfolio of pharmaceutical products from over 350 Egyptian and multinational pharmaceutical companies to more than 49,000 customers, including pharmacies, hospitals, retail outlets, and wholesalers using a fleet of around 830 vehicles.
